ultiple molecules to human studies, raised >$50m in start up financing; part of early or founding management at Semafore Pharmaceuticals, Simdesk, Kinagen, Endgenitor, Naurex, and other start ups 22+ years in pharma discovery; former VP of US Research for OSI, inventor of Tarceva@, leading cancer dr